top of page
  • Writer's pictureatharva hingane

General Influenza Diagnostics Market, Global Outlook and Forecast 2023-2030

Influenza virus testing is not required to make a clinical diagnosis of Influenza in outpatients with suspected Influenza,Particularly during increased state-run activity when seasonal state-run influenza A and B viruses are circulating in the local community. The traditional detection methods include: RIDT, Viral Culture, DFA, Serological assays.

This report aims to provide a comprehensive presentation of the global market for General Influenza Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding General Influenza Diagnostics. This report contains market size and forecasts of General Influenza Diagnostics in global, including the following market information:

  • Global General Influenza Diagnostics Market Revenue, 2018-2023, 2024-2030, ($ millions)

  • Global top five companies in 2022 (%)

Report Sample includes: - Table of Contents - List of Tables & Figures - Charts - Research Methodology Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-general-influenza-diagnostics-forecast-2023-2030-386


The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.

RIDT Segment to Reach $ Million by 2029, with a % CAGR in next six years.

The global key manufacturers of General Influenza Diagnostics include F. Hoffmann-La Roche, Quidel Corporation, Thermo Fisher Scientific, Abbott Laboratories, Becton, Dickinson, and Company, DiaSorin and bioM?rieux, etc. in 2022, the global top five players have a share approximately % in terms of revenue.

We surveyed the General Influenza Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global General Influenza Diagnostics Market, by Type, 2018-2023, 2024-2030 ($ millions)

Global General Influenza Diagnostics Market Segment Percentages, by Type, 2022 (%)


  • RIDT

  • Viral Culture

  • DFA

  • Serological Assays

Global General Influenza Diagnostics Market Segment Percentages, by Application, 2022 (%)


  • Hospitals

  • Clinical Laboratories

  • Other End-User

Global General Influenza Diagnostics Market Segment Percentages, By Region and Country, 2022 (%


  • North America

  • US

  • Canada

  • Mexico

  • Europe

  • Germany

  • France

  • U.K.

  • Italy

  • Russia

  • Nordic Countries

  • Benelux

  • Rest of Europe

  • Asia

  • China

  • Japan

  • South Korea

  • Southeast Asia

  • India

  • Rest of Asia

  • South America

  • Brazil

  • Argentina

  • Rest of South America

  • Middle East & Africa

  • Turkey

  • Israel

  • Saudi Arabia

  • UAE

  • Rest of Middle East & Africa

The report also provides analysis of leading market participants including:


  • Key companies General Influenza Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)

  • Key companies General Influenza Diagnostics revenues share in global market, 2022 (%)


  • F. Hoffmann-La Roche

  • Quidel Corporation

  • Thermo Fisher Scientific

  • Abbott Laboratories

  • Becton, Dickinson, and Company

  • DiaSorin

  • bioM?rieux

Chapter 1: Introduces the definition of General Influenza Diagnostics, market overview.

Chapter 2: Global General Influenza Diagnostics market size in revenue.

Chapter 3: Detailed analysis of General Influenza Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of General Influenza Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: The main points and conclusions of the report.

CONTACT US:

276 5th Avenue, New York , NY 10001,United States

International: (+1) 646 781 7170

1 view0 comments

Recent Posts

See All

Comments


bottom of page